Riskpilot← Back to searchSign inGet full accessGeneral Orthopedics Int. AB
ABDissolvedOrg 5566146782Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20010 employees
Revenue 2019
SEK 0
EBITDA margin
—
+67% vs 2018
Equity ratio
98.3%
Financial strength
Net profit 2019
SEK 0
0 employees
| Revenue | SEK 0 | — |
| EBITDA | SEK -57K | +67% |
| Net profit | SEK 0 | — |
| Total assets | SEK 352K | -4% |
| Equity | SEK 346K | +0% |
| Employees | 0 | — |
Legal name
General Orthopedics Int. AB
Org number
5566146782
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
24 oktober 2001
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Company purpose
Föremålet för bolagets verksamhet är att omfatta följande område: 1. Forskning och utveckling a. frakturfixation, b. nivådiagnostik perifiera nervskador. 2. Utbidlningsverksmahet inom ovanstående a. föreläsning, b. workshop, c. operationsdemonstration 3. Konsultverksamhet ovanstående områden 4. Produktion och försaäljning av till ovanstående områden hörande produkter. 5. Äga och förvalta lös egendom samt bedriva finansiell konsultverksamhet och därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — |
| EBITDA | −186 | −58 | −173 | −57 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −186 | −58 | −173 | −57 |
| Net financials | 4 | — | — | — |
| Profit before tax | −182 | 183 | 0 | 0 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −182 | 183 | 0 | 0 |
| Item | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|
| Total assets | 187 | 355 | 367 | 352 |
| Equity | 162 | 345 | 346 | 346 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 25 | 10 | 21 | 6 |
| Total debt | 25 | 10 | 21 | 6 |
EBITDA margin
-5700000.0%
This company
15.8%
Market median
-36076049% vs market
20162019
Equity ratio
98.3%
This company
38.2%
Market median
+157% vs market
20162019
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20162019
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20162019
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162019
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20162019
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
KG Audit | Audit | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Deputy Board Member | 2020 – 2021 | |
| Board of Directors | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of General Orthopedics Int. AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Göran Johansson | Audit | 0 companies |
| Ingegerd Viveca Hansson | Deputy Board Member | 0 companies |
| Lars Johan Henrik Hansson | Board of Directors | 0 companies |